These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11258354)

  • 1. Duty to re-contact.
    Hirschhorn K; Fleisher LD; Godmilow L; Howell RR; Lebel RR; McCabe ER; McGinniss MJ; Milunsky A; Pelias MZ; Pyeritz RE; Sujansky E; Thompson BH; Zinberg RE
    Genet Med; 1999; 1(4):171-2. PubMed ID: 11258354
    [No Abstract]   [Full Text] [Related]  

  • 2. The duty to recontact: benefit and harm.
    Sharpe NF
    Am J Hum Genet; 1999 Oct; 65(4):1201-4. PubMed ID: 10486341
    [No Abstract]   [Full Text] [Related]  

  • 3. Recontact practices of cancer genetic counselors and an exploration of professional, legal, and ethical duty.
    Mueller A; Dalton E; Enserro D; Wang C; Flynn M
    J Genet Couns; 2019 Aug; 28(4):836-846. PubMed ID: 31058402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duty to re-contact: a study of families at risk for Fragile X.
    Bernard LE; McGillivray B; Van Allen MI; Friedman JM; Langlois S
    J Genet Couns; 1999 Feb; 8(1):3-15. PubMed ID: 11657178
    [No Abstract]   [Full Text] [Related]  

  • 5. Re-contact to advise of testing available to detect high risk for carcinoma: response to letters sent to persons initially ascertained for other genetic reasons.
    Swiglo BA; Lebel RR
    Am J Hum Genet; 1997 Oct; 61(4):A390. PubMed ID: 11644970
    [No Abstract]   [Full Text] [Related]  

  • 6. The duty to recontact: attitudes of genetics service providers.
    Fitzpatrick J; Hahn C; Costa T; Huggins M
    Am J Hum Genet; 1997 Oct; 61(4):A57. PubMed ID: 11644972
    [No Abstract]   [Full Text] [Related]  

  • 7. The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results.
    Bombard Y; Brothers KB; Fitzgerald-Butt S; Garrison NA; Jamal L; James CA; Jarvik GP; McCormick JB; Nelson TN; Ormond KE; Rehm HL; Richer J; Souzeau E; Vassy JL; Wagner JK; Levy HP
    Am J Hum Genet; 2019 Apr; 104(4):578-595. PubMed ID: 30951675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A duty to recontact in genetics: context matters.
    Giesbertz NAA; van Harten WH; Bredenoord AL
    Nat Rev Genet; 2019 Jul; 20(7):371-372. PubMed ID: 30932026
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature.
    Otten E; Plantinga M; Birnie E; Verkerk MA; Lucassen AM; Ranchor AV; Van Langen IM
    Genet Med; 2015 Aug; 17(8):668-78. PubMed ID: 25503495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staying informed and recontacting patients about research advances: a study of patient attitudes.
    Huggins M; Hahn C; Costa T
    Am J Hum Genet; 1996 Oct; 59(4):A335. PubMed ID: 11644832
    [No Abstract]   [Full Text] [Related]  

  • 11. Equity implications of patient-initiated recontact and follow-up in clinical genetics.
    Mackley MP; Chad L
    Eur J Hum Genet; 2023 May; 31(5):495-496. PubMed ID: 36959498
    [No Abstract]   [Full Text] [Related]  

  • 12. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors.
    ;
    Am J Hum Genet; 1995 Nov; 57(5):1233-41. PubMed ID: 7485175
    [No Abstract]   [Full Text] [Related]  

  • 13. The duty to re-contact for newly appreciated risk factors: fragile X premutation.
    Guzauskas GF; Lebel RR
    J Clin Ethics; 2006; 17(1):46-52. PubMed ID: 16689113
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic testing and human subjects in research.
    Laidlaw SA; Raffel LJ; Daar JF
    Whittier Law Rev; 2002; 24(2):429-72. PubMed ID: 15085855
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic secrets and the family.
    Bell D; Bennett B
    Med Law Rev; 2001; 9(2):130-61. PubMed ID: 12778930
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic secrets and the family: a response to Bell and Bennett.
    Skene L
    Med Law Rev; 2001; 9(2):162-9. PubMed ID: 12778931
    [No Abstract]   [Full Text] [Related]  

  • 17. ASHG statement. Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure.
    Am J Hum Genet; 1998 Feb; 62(2):474-83. PubMed ID: 9537923
    [No Abstract]   [Full Text] [Related]  

  • 18. Experts reflecting on the duty to recontact patients and research participants; why professionals should take the lead in developing guidelines.
    Mitchell C; Ploem C; Retèl V; Gevers S; Hennekam R
    Eur J Med Genet; 2020 Feb; 63(2):103642. PubMed ID: 30904667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torts and the double helix: malpractice liability for failure to warn of genetic risks.
    Andrews LB
    Houst Law Rev; 1992; 29(1):149-84. PubMed ID: 11656665
    [No Abstract]   [Full Text] [Related]  

  • 20. When do genetic researchers have a duty to recontact study participants?
    Wade CH; Kalfoglou AL
    Am J Bioeth; 2006; 6(6):26-7; author reply W10-2. PubMed ID: 17085400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.